繁體
  • 简体中文
  • 繁體中文
×

熱門資訊> 正文

莫勒克收到纳斯达克决定书

2025-11-22 06:55

  • Moolec Science (NASDAQ:MLEC) announced on Friday the receipt of a determination letter from Nasdaq indicating that the closing bid price of the company's ordinary shares had been below the minimum $1.00 per share requirement for the last 30 consecutive business days, as stated in Nasdaq Listing Rule 5550(a)(2).
  • The company has submitted a timely appeal to a Nasdaq Hearings Panel, requesting the grant of a 180-day period to submit and effect a compliance plan, which will include a potential implementation of a reverse stock split, if needed.
  • The submission of the appeal automatically stays the effect of the Nasdaq Determination Letter until the appeal has been considered, which will take place on December 18, 2025.
  • Shares -4.38%.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
（工作日09：30 - 次日05：30）
客戶端：
關注我們：
  • 微信公眾號二維碼

© 2025 深圳市時代華盛網絡科技有限公司版權所有 粵ICP備16068286號